Session 2: $399

  • Anatomy of Financial Statements
  • Financial Due Diligence
  • Valuation of a Start-Up
  • Capitalization Tables
  • Term Sheets

By session end, you will understand:

  • How to read the 3 key financial statements of any venture
  • How to derive the valuation of a venture using multiple approaches
  • The basic elements of terms sheets, including those for convertible notes and equity based investments
  • How to develop and read capitalization tables to understand who owns what percentage of a venture
  • How to optimize terms to obtain the best Investment or start-up capitalization deal

Course 2 Registration - 45 day access

  • Price: $399.00
    Refund Policy: 100% within 24 hours of purchase. 50% within 48 hours of purchase. No refund thereafter. Limitations of Liability: This online course does not endorse or make any representations or warranties concerning companies presented. Content of all lessons is for educational purposes only. The organizers disclaim any liability for investment losses or damages flowing from Participant’s individual investment decisions. Participants should obtain independent legal and financial advice prior to making any investment decision. All Participants understand that they will hold harmless the course organizers, instructors, sponsors and ECF Biosolutions for any investment decisions and outcomes. which result in a loss. The course organizers, instructors, sponsors and ECF Biosolutions do not constitute a venture fund, investment bank,broker/dealer, investment clearinghouse, or any other form of investment advisor or otherwise, and are not registered with the Securities and Exchange Commission or any state securities commission. They do not provide advice, recommendations, or any other indications of appropriateness or inappropriateness for a particular investment. Confidentiality of Material: All educational content is being furnished on a confidential basis. By accepting the material, the registrant agrees to keep confidential the information contained herein. Any unauthorized use, distribution, or reproduction of the material is prohibited. All sales are final.
  • American Express
  • $0.00


John Brzezenski, MBA

  • Partner, J. Locke and Co
  • Member and Former Board Chair, Launchpad Ventures

25+ years broad-based experience spanning private equity, operating & executive mgmt & advisory roles. Partner for Strategy/M&A Advisory firm, Member of Investment Committee for a VC firm, Partner at numerous boutique advisory firms including Tempo Advisor and J. Locke  & Co,  a merchant bank. Experience across all company stages and numerous sectors including high tech, medical & health-related, chemical & process industries.  Long-time angel investor, members & former Board Chair, Launchpad Ventures of New England.  BA, Harvard, MBA, Northwestern Kellogg.

Elizabeth Cho-Fertikh, PhD

  • Founder, ECF Biosolutions
  • Partner, 1812 Ventures

Angel investor & venture capital partner.  20 years cancer research, high impact scientific journal publications, biotech R&D, regulatory and management experience for dozens of start-ups and industry, including MacroGenics, Gore Medical, Beckman Coulter, Amgen.  BA, Johns Hopkins, PhD, Thomas Jefferson University, Postdoctoral Training, Harvard Medical School.